HOB Biotech Group Corp.,Ltd (688656.SS) SHH
107.64
-3.47(-3.12%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
HOB Biotech Group Corp.,Ltd
Sector
Healthcare
Industry
Medical - Devices
Employees
529
First IPO Date
January 13, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Chun Li Li | Accounting Supervisor | 0 | N/A |
| Qingxin Liu | Director & Deputy GM | 0 | 1974 |
| Ruoliang Sun | Deputy General Manager | 0 | 1972 |
| Xiaohua Huang | Deputy General Manager | 0 | 1974 |
| Aixiang Xie | Secretary | 0 | 1982 |
| Shuyan Han | Chief Financial Officer | 0 | 1980 |
| John Li | Chairman & GM | 0 | 1963 |
Description
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.
